LAURA REGAN: Open Payments
NPI 1538591821 · NORTH RICHLAND HILLS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$200 in 10 payments from 7 companies in 2025. Trend: 2023 $57 · 2024 $236 · 2025 $200
Food & beverage: $200
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 3 | $54 |
| Medtronic, Inc. | 2 | $42 |
| Optinose US, Inc. | 1 | $27 |
| GENZYME CORPORATION | 1 | $26 |
| Smith+Nephew, Inc. | 1 | $21 |
| Phathom Pharmaceuticals, Inc. | 1 | $16 |
| ALK-Abello, Inc | 1 | $14 |
Products named: NUCALA, PROPEL, Xhance, DUPIXENT, HALO, VOQUEZNA, TIMOTHY, STANDARDIZED.
Industry payments across TX — which companies pay providers there.
